ArticlePediatric blood & cancer2020
Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Open access · bronzeAbstract readMulticenter StudyConsensus Statement
In one paragraph
Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- Exploring the Impact of COVID-19 on Mental Health Outcomes in Children and Adolescents: A Systematic Review.International journal of environmental research and public health · 2020Pooled it
- Risk factors for postoperative recurrence of thyroid cancer patients in children, adolescents, and young adults.Translational pediatrics · 2026Article
- Understanding caregivers' decision to vaccinate childhood cancer survivors against COVID-19.Cancer medicine · 2023Article
- Impact of COVID-19 on Lifestyle Habits and Emotional State of Childhood Cancer Survivors and Their Parents.Nutrients · 2023Article
- Psychosocial impact of COVID-19 on caregivers and adolescents and young adult survivors of childhood cancer.Pediatric blood & cancer · 2023Article
- Experiences of adolescent and young adult cancer survivors during the COVID-19 pandemic.Journal of cancer survivorship : research and practice · 2023Article
- Food Insecurity and Nutritional Challenges in Adolescent and Young Adult Cancer Survivors in the U.S.A.: A Narrative Review and Call to Action.Nutrients · 2023Review
- Five tips for conducting remote qualitative data collection in COVID times: theoretical and pragmatic considerations.Revista da Escola de Enfermagem da U S P · 2023Article
- Childhood cancer survivorship care during the COVID-19 pandemic: an international report of practice implications and provider concerns.Journal of cancer survivorship : research and practice · 2022Article
- The chance of transition: strategies for multidisciplinary collaboration.Endocrine connections · 2022Review
- Article
- SARS-CoV-2 in children with cancer or after haematopoietic stem cell transplant: An analysis of 131 patients.European journal of cancer (Oxford, England : 1990) · 2021Observational
- Virtual visits as long-term follow-up care for childhood cancer survivors: Patient and provider satisfaction during the COVID-19 pandemic.Pediatric blood & cancer · 2021Article
- The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global.Pediatric blood & cancer · 2021Article
- Impacts of COVID-19 on caregivers of childhood cancer survivors.Pediatric blood & cancer · 2021Article
- COVID-19 in pediatric survivors of childhood cancer and hematopoietic cell transplantation from a single center in New York City.Pediatric blood & cancer · 2021Article
- A Population-Based Study of COVID-19 Infection Among Childhood Cancer Survivors.Frontiers in medicine · 2021Article
- Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer: A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group.Pediatric blood & cancer · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
40 authors at 20 institutions in 15 countries.
Lisanne C VerbruggenPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.ORCID https://orcid.org/0000-0002-5677-4836
Yuehan WangPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Saro H ArmenianDepartment of Population Sciences, City of Hope National Medical Center, Duarte, California, USA.
Matthew J EhrhardtDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Helena J H van der PalPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Elvira C van DalenPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Jorrit W van AsCochrane Childhood Cancer, Amsterdam, the Netherlands.
Edit BardiSt Anna Childrens Hospital, Vienna, Austria.ORCID https://orcid.org/0000-0001-7424-6255
Katja BaustDepartment for Pediatric Hematology and Oncology, University Hospital Bonn, Bonn, Germany.
Claire BergerDepartment for Pediatric Hematology and Oncology CHU Nord, University Hospital Saint-Etienne, Saint-Priest en Jarez, France.
Elio CastagnolaInfectious Diseases Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy.ORCID https://orcid.org/0000-0002-5336-8429
Katie A DevineRutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, New Jersey, USA.
Judith GebauerInstitute for Endocrinology and Diabetes, University of Luebeck, Ratzeburger Allee 160, Luebeck, 23562, Germany.
Jordan Gilleland MarchakEmory University School of Medicine, Aflac Cancer and Blood Disorders Center, Atlanta, Georgia, USA.
Adam W GlaserDepartment of Paediatric Oncology, Leeds Teaching Hospitals NHS Trust and Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK.
Andreas H GrollInfectious Disease Research Program, Center for Bone Marrow Transplantation and Department of Pediatric Hematology/Oncology University Children's Hospital, Münster, Germany.
Gabrielle M HaeuslerNHMRC National Centre for Infections in Cancer, Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Jaap den HartoghDutch Childhood Cancer Parent Organization VOKK Netherlands, Department VOX Survivors, Nieuwegein, the Netherlands.
Riccardo HauptEpidemiology and Biostatistics Unit and DOPO clinic IRCCS Istituto Giannina Gaslini, Genova, Italy.
Lars HjorthLund University, Skane University Hospital, Department of Clinical Sciences Lund, Pediatrics, Lund, Sweden.
Miho KatoDepartment of Pediatric Hematology/Oncology, Okinawa Prefectural Nanbu Medical Center and Children's Medical Center, Okinawa, Japan.
Tomáš KepákUniversity Hospital Brno and St. Anna University Hospital/ICRC, Masaryk University, Brno, Czech Republic.
Maria M W Rianne KoopmanPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Thorsten LangerUniversity Hospital for Children and Adolescents, Pediatric Oncology and Hematology, Ratzeburger Allee 160, Luebeck, 23562, Germany.
Miho MaedaDepartment of Pediatrics, Nippon Medical School, Tokyo, Japan.
Gisela MichelDepartment of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.ORCID https://orcid.org/0000-0002-9589-0928
Monica MuracaEpidemiology and Biostatistics Unit and DOPO Clinic IRCCS Istituto Giannina Gaslini, Genova, Italy.
Paul C NathanThe Hospital for Sick Children, Toronto, Canada.ORCID https://orcid.org/0000-0003-0334-0871
Selina R van den OeverPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Vesna PavasovicDepartment of Malignant Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
Satomi SatoSt. Luke's International University, Tokyo, Japan.
Fiona SchulteDepartment of Oncology, Division of Psychosocial Oncology, University of Calgary, Calgary, AB, Canada.ORCID https://orcid.org/0000-0002-3076-9676
Lillian SungDivision of Haematology/Oncology, The Hospital for Sick Children, Toronto, Canada.
Wim TissingPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Anne UyttebroeckDepartment of Pediatric Hematology and Oncology, University Hospitals Leuven, Leuven, Belgium.
Renée L MulderPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Claudia KuehniChildhood Cancer Registry (ChCR), Institute for Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID https://orcid.org/0000-0001-8957-2002
Roderick SkinnerDepartment of Paediatric and Adolescent Haematology/Oncology, Great North Children's Hospital, and Clinical and Translational Research Institute, Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
Melissa M HudsonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Leontien C M KremerPrincess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Princess Máxima Center · NLIstituto Giannina Gaslini · ITSt. Jude Children's Research Hospital · USChildren's Medical Center · USCity Of Hope National Medical Center · USDélégation Paris 5 · FRDuchenne Parent Project · NLEmory University · USGreat North Children's Hospital · GBGreat Ormond Street Hospital · GBHospital for Sick Children · CAInstitute for Integrative and Experimental Genomics · DEKepler Universitätsklinikum · ATKU Leuven · BELund University · SEMasaryk University · CZNippon Medical School · JPRoyal Children's Hospital · AURutgers, The State University of New Jersey · USStichting Kinderoncologie Nederland · NL
Funding
No grant is acknowledged in the PubMed record.
Abstract
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.
Indexed as
BetacoronavirusCancer SurvivorsAdolescentAdultChildChild, PreschoolCoronavirus InfectionsCOVID-19FemaleHumansMaleNeoplasmsPandemicsPneumonia, ViralPractice Guidelines as TopicSARS-CoV-2childhood adolescent and young adult (CAYA) cancer survivorsCOVID-19late effects of cancer treatment
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.